Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary presents a mixed outlook. While there are positive developments like new business opportunities in digital infrastructure and AI-driven productivity gains, there are also challenges such as headwinds in property cat pricing and unclear growth prospects for RIS. The Q&A section reveals management's vague responses on certain issues, which could raise investor concerns. The lack of clear strategic guidance and the mixed economic environment suggest a neutral impact on stock price over the next two weeks.
Total Revenue $27 billion, a 10% increase year-over-year, with underlying revenue growth of 4%. The growth was attributed to strong execution against strategic objectives.
Adjusted Operating Income $7.3 billion, an 11% increase year-over-year. This growth followed an 11% increase in 2024, driven by operational efficiency and strategic execution.
Adjusted Operating Margin Improved by 30 basis points, marking the 18th consecutive year of reported margin expansion.
Adjusted EPS $9.75 for the full year, a 9% increase year-over-year, reflecting strong financial performance.
Free Cash Flow Increased by 25% to $5 billion, driven by disciplined working capital management and strong business performance.
Capital Deployment $850 million invested in acquisitions and $2 billion in share repurchases, the largest annual amount in the company's history. Additionally, there was a 10% increase in the quarterly dividend.
Consolidated Revenue (Q4) $6.6 billion, a 9% increase year-over-year, with underlying growth of 4%. Growth was supported by 2% growth in Risk & Insurance Services (RIS) and 5% in Consulting.
Adjusted Operating Income (Q4) $1.6 billion, a 12% increase year-over-year, reflecting strong execution despite a challenging environment.
Adjusted EPS (Q4) $2.12, a 10% increase year-over-year, driven by operational efficiency and revenue growth.
Risk & Insurance Services Revenue (Full Year) $17.3 billion, with underlying growth of 4%. Adjusted operating income increased 12% to $5.5 billion, and the adjusted operating margin was 32%.
Consulting Revenue (Full Year) $9.8 billion, reflecting underlying growth of 5%. Adjusted operating income increased 10% to $2.1 billion, and the adjusted operating margin increased 40 basis points to 21.1%.
Mercer Revenue (Q4) $1.6 billion, a 9% increase year-over-year, with underlying growth of 4%. Growth was driven by Health (6%) and Wealth (5%).
Marsh Management Consulting Revenue (Q4) $1 billion, an 8% increase year-over-year, reflecting solid demand across most regions and sectors.
Fiduciary Interest Income (Q4) $92 million, down $20 million year-over-year, reflecting lower interest rates.
Free Cash Flow (Full Year) $5 billion, up from $4 billion in the previous year, reflecting strong business performance and disciplined working capital management.
Thrive Program: Introduced to provide financial flexibility and organizational agility over the next 3 years. Focuses on investments in digital infrastructure, healthcare, private capital, insurance capital strategies, and energy. Includes AI-driven productivity tools and client-facing technologies like Sentrisk and Aida.
New Marsh Brand: Launched a unified brand to simplify value proposition and support business strategy. Includes a new ticker symbol MRSH.
Insurance and Reinsurance Market: Primary commercial insurance rates decreased 4% in Q4 2025. U.S. rates were flat, while other regions like the U.K., Canada, and Latin America saw declines. Reinsurance market saw price decreases and increased demand, with a record $24 billion in cat bonds issued.
Health Trends: Medical costs are expected to rise by 7% in the U.S. in 2026, with high single to low double-digit increases in other regions.
Operational Efficiencies: BCS (Business and Client Services) introduced to harness AI and advanced analytics for improved client outcomes and operational excellence. Expected to generate $400 million in savings, with $500 million in associated charges.
Financial Performance: 2025 revenue grew 10% to $27 billion, with adjusted operating income up 11% to $7.3 billion. Adjusted EPS increased 9% to $9.75. Free cash flow grew 25% to $5 billion.
Capital Deployment: Invested $850 million in acquisitions and returned $2 billion to shareholders through share repurchases. Increased quarterly dividend by 10%.
Market Positioning: Aims to be the most impactful professional services firm globally, expanding beyond insurance into risk, reinsurance, health, and management consulting.
Competitive Insurance and Reinsurance Environment: The company faces a competitive insurance and reinsurance market, with primary commercial insurance rates decreasing 4% in Q4 2025. This includes declines in property rates globally and financial and professional liability rates, which could impact revenue growth.
Rising Medical Costs: Medical costs are expected to rise by 7% in the U.S. and high single to low double digits in other regions in 2026, posing challenges for clients and potentially impacting the company's health-related services.
Economic and Market Uncertainty: The company acknowledges a complex environment with polycrises such as trade wars, social unrest, and AI disruption, which could create operational and strategic challenges.
Expense Management and Thrive Program Costs: The Thrive program aims to generate $400 million in savings but will incur approximately $500 million in charges, creating short-term financial pressures.
Interest Rate and Fiduciary Income Headwinds: Lower interest rates have led to a decline in fiduciary interest income, which is expected to continue into 2026, impacting financial performance.
Casualty Market Pressure: Global casualty rates increased 4%, with U.S. excess casualty up 19%, reflecting ongoing liability pressures that could affect the company's risk and insurance services.
Softening Reinsurance Market: The property catastrophe reinsurance market is softening, with price decreases and increased demand for better risk-sharing arrangements, which could impact profitability.
Revenue Growth: The company expects underlying revenue growth in 2026 to be similar to the 4% growth achieved in 2025.
Margin Expansion: Continued margin expansion is anticipated in 2026.
Adjusted EPS Growth: Solid adjusted EPS growth is expected in 2026.
Thrive Program: The Thrive program is expected to generate $400 million in total savings, with a portion reinvested for growth, and incur approximately $500 million in charges to achieve these savings.
Fiduciary Interest Income: Fiduciary interest income is expected to be approximately $83 million in Q1 2026.
Interest Expense: Interest expense is forecasted to be approximately $240 million in Q1 2026.
Adjusted Effective Tax Rate: The adjusted effective tax rate for 2026 is expected to be between 24.5% and 25.5%.
Capital Deployment: Approximately $5 billion is expected to be deployed across dividends, acquisitions, and share repurchases in 2026.
Medical Cost Trends: Medical costs are projected to rise by 7% in the U.S. and high single to low double digits in other regions in 2026.
Insurance and Reinsurance Market: The company anticipates a competitive insurance and reinsurance environment, with decreasing pricing trends in primary commercial insurance and reinsurance markets.
Quarterly Dividend Increase: 10% increase in quarterly dividend in 2025.
Total Dividends Paid in 2025: $1.7 billion paid in dividends for the full year.
Share Repurchase Program: $2 billion in share repurchases in 2025, the largest annual amount in the company's history.
Q4 Share Repurchases: $1 billion of stock repurchased in the fourth quarter of 2025.
2026 Share Repurchase Outlook: Approximately $5 billion expected to be deployed across dividends, acquisitions, and share repurchases in 2026, with the level of share repurchase depending on the M&A pipeline.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.